Expert Insights
Channels
Themes
Active ETFs
Financial Literacy
Artificial Intelligence
Fixed Income
Beyond Basic Beta
Free Cash Flow
China Insights
Innovative ETFs
Climate Insights
Institutional Income Strategies
Core Strategies
Leveraged & Inverse
Crypto
Managed Futures
Market Insights
Disruptive Technology
Modern Alpha
Energy Infrastructure
Multifactor
ETF Building Blocks
Responsible Investing
ETF Education
Retirement Income
ETF Investing
Tax Efficient Income
ETF Strategist
Asset Class
Equity
U.S. Equity
Int'l Developed
Emerging Market Equities
Fixed Income
Investment Grade Corporates
US Treasuries & TIPS
High Yield Corporates
Int'l Fixed Income
Alternatives
Commodities
Gold/Silver/Critical Minerals
Currency
Volatility
ETF Ecosystem
ETFs in Canada
Webcasts
Popular ETFs
SPY – SPDR S&P 500 ETF
VOO – Vanguard S&P 500 ETF
QQQ – Invesco QQQ ETF
GLD – SPDR Gold Shares ETF
IVV – iShares Core S&P 500 ETF
EFA - iShares MSCI EAFE ETF
EEM – iShares MSCI Emerging Markets ETF
IEMG – iShares Core MSCI Emerging Markets ETF
VTI – Vanguard Total Stock Market ETF
GDX - VanEck Vectors Gold Miners ETF
XLF - Financial Select Sector SPDR Fund
VEA – Vanguard FTSE Developed Markets ETF
VTV - Vanguard Value ETF
Top Gold ETFs
Top Oil ETFs
Top Commodity ETFs
Top Hedge Fund ETFs
Top Financials ETFs
Top Inverse Equities ETFs
Top High Yield Bond ETFs
Education & Media
Newsletter
New ETFs
Education Central
Videos
ETF of the Week Podcast
ETF Prime Podcast
ETF 360 Video Series
Exchange
Events
Exchange
Equity Symposium
AI Symposium
Fixed Income Symposium
Company
About VettaFi
Get VettaFi’ed
LABU
Equity ETFs
Catalysts Abound for Biotech ETFs
By
Tom Lydon
April 10, 2018
Equity ETFs
Betting Big on Biotech ETFs? Traders Leverage ETFs
By
Brenton Garen
March 28, 2018
Equity ETFs
Good Reasons to Stick With Biotech ETFs
By
Tom Lydon
March 12, 2018
Equity ETFs
Healthcare Dip Could be a Buying Opportunity
By
Brenton Garen
February 5, 2018
Equity ETFs
Biotech ETFs Pop on Celgene, Juno Deal
By
Max Chen
January 22, 2018
Equity ETFs
Adding Some Juice to the Healthcare Trade
By
Tom Lydon
January 10, 2018
Equity ETFs
Biotech Slump Could be a Buying Opportunity
By
Tom Lydon
December 5, 2017
Equity ETFs
Biotech Decline Could be a Buying Opportunity
By
Brenton Garen
November 16, 2017
Equity ETFs
Bullish Biotech Bets After Positive Attention
By
Tom Lydon
October 5, 2017
Equity ETFs
A Good Time to Own Biotech ETFs
By
Tom Lydon
October 2, 2017
Equity ETFs
Evaluating the Biotech ETF Rally
By
Tom Lydon
September 28, 2017
Equity ETFs
Biotech, Pharma ETFs Leave Pricing Drama Behind
By
Max Chen
September 15, 2017
Equity ETFs
Biotech ETF Investing is Hot, Can Get Hotter
By
Tom Lydon
September 8, 2017
Equity ETFs
Biotech ETFs Remain Bell of the Ball
By
Brenton Garen
September 1, 2017
Equity ETFs
September Could be Kind to Biotechnology ETFs
By
Brenton Garen
August 29, 2017
Equity ETFs
Biotech ETFs Prescribe Investing Momentum
By
Tom Lydon
July 24, 2017
Equity ETFs
Big Biotech ETF Bounce Looks for More Upside
By
Brenton Garen
June 30, 2017
Equity ETFs
Encouraging Signs for a Big Biotech ETF
By
Tom Lydon
May 8, 2017
Previous
1
2
3
4
Next
X
